Tilda is a technology-led site network that Sponsors and CROs rely on to carry out high-performance studies and first-rate patient care. Technology, Diversity, Quality. These are the 3 pillars that define our approach and outline why Sponsors & CROs choose Tilda. We have 4 dedicated research centers across Southern California and Alabama, where we've conducted over 250 trials, caring for more than 2,500 patients. Our 15 Investigators specialize in 9 major therapeutic areas (Cardiovascular, CNS & Psychiatric, Metabolic, and Musculoskeletal), covering phase 2-3 trials.